Sort
10,766 grants matching “checkpoint inhibitor”
Role of B-cell mediated anti-tumor antibodies in responses to radiation and immunotherapy in HNSCC
$366,306Andrew B. Sharabi · University Of California, San Diego · R01 · FY2020 · DE
Targeting cellular double-stranded RNA homeostasis in breast cancer
$366,299Cecil Han · Georgetown University · R01 · FY2023 · CA
Metabolic interactions between tumor cells and the immune system in GBM: A potential Achilles heel of GBM for novel therapeutics
$366,265Loic Pierre Deleyrolle · Mayo Clinic Jacksonville · R01 · FY2025 · NS
The Pancreatic Cancer Microenvironment
$366,246Rui Kang · Ut Southwestern Medical Center · R01 · FY2023 · CA
Project 2: Androgen deprivation as an immune modulating therapy in combination with targeted immunotherapy of prostate cancer
$366,237Douglas G McNeel · University Of Wisconsin-Madison · P50 · FY2025 · CA
Mitochondrial stress promotes immunosuppressive potential of myeloid subsets in tumors
$366,172Paulo Cesar Rodriguez · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2024 · CA
Reprogramming myeloid cells to inhibit cancer development
$366,170Chengcheng Zhang · Ut Southwestern Medical Center · R01 · FY2023 · CA
In Situ characterization and manipulation of tumor immune cell metabolomics using implantable microdevices
$366,134Oliver Jonas · Brigham And Women'S Hospital · R01 · FY2018 · CA
(PQ11) Targeting STING in the context of chemoradiation therapy to overcome poor preexisting immunity in mouse models of pancreatic cancer.
$366,114Marka Crittenden · Providence Portland Medical Center · R01 · FY2019 · CA
A druggable dependency in low-MITF/high-AXL melanoma: preclinical efficacy and mechanism of action in a key treatment-resistant subclass.
$366,076David E Fisher · Massachusetts General Hospital · R01 · FY2022 · CA
Gene expression signature based screening in Ewing sarcoma
$366,059David J Gordon · University Of Iowa · R37 · FY2019 · CA
Role of B-cell mediated anti-tumor antibodies in responses to radiation and immunotherapy in HNSCC
$366,015Andrew B. Sharabi · University Of California, San Diego · R01 · FY2019 · DE
Genome-wide mapping and characterization of exitrons in human cancer
$366,003Rendong Yang · Northwestern University At Chicago · R01 · FY2022 · CA
Use of Patient-Reported Outcomes in Understanding Symptomatic Adverse Events in Early-Phase Trials of Combination Treatments that Include Immune Checkpoint Inhibitors and Targeted Therapy
$366,000Tito R Mendoza · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
Development of Long non-coding RNA-directed Target Therapy for Triple-Negative Breast Cancer
$366,000Chunru Lin · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA
Therapeutic strategies for targeting PARP1 in small cell lung cancer
$366,000Lauren Averett Byers · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · CA
Therapeutic strategies for targeting PARP1 in small cell lung cancer
$366,000Lauren Averett Byers · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
Novel regulations of DNA damage repair
$366,000Junjie Chen · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · CA
The Role of Epithelial-Mesenchymal Transition in Re-Wiring KRAS Mutant Lung Cancer
$366,000Don Lynn Gibbons · University Of Tx Md Anderson Can Ctr · R37 · FY2022 · CA
53BP1-dependent pathway in DNA repair
$366,000Junjie Chen · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Development of Long non-coding RNA-directed Target Therapy for Triple-Negative Breast Cancer
$366,000Chunru Lin · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Use of Patient-Reported Outcomes in Understanding Symptomatic Adverse Events in Early-Phase Trials of Combination Treatments that Include Immune Checkpoint Inhibitors and Targeted Therapy
$366,000Tito R Mendoza · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA
Therapeutic strategies for targeting PARP1 in small cell lung cancer
$366,000Lauren Averett Byers · University Of Tx Md Anderson Can Ctr · R01 · FY2018 · CA
Therapeutic strategies for targeting PARP1 in small cell lung cancer
$366,000Lauren Averett Byers · University Of Tx Md Anderson Can Ctr · R01 · FY2016 · CA
A novel pathway to overcome resistance to immunotherapy in melanoma
$366,000Diana Nora Vaz Saleiro · Northwestern University At Chicago · R01 · FY2024 · CA